$HRGN
Harvard Apparatus Regenerative Technology Inc

2014 Q2 Form 10-Q Financial Statement

#000114420414031376 Filed on May 15, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2014 Q1 2013 Q1
Revenue $23.00K $23.00K $0.00
YoY Change
Cost Of Revenue $12.00K $12.00K $0.00
YoY Change
Gross Profit $11.00K $11.00K $0.00
YoY Change
Gross Profit Margin 47.83% 47.83%
Selling, General & Admin $1.330M $1.800M $860.0K
YoY Change 62.2% 109.3%
% of Gross Profit 12090.91% 16363.64%
Research & Development $1.214M $1.217M $1.160M
YoY Change -4.41% 4.91%
% of Gross Profit 11036.36% 11063.64%
Depreciation & Amortization $90.00K $56.00K $38.00K
YoY Change 125.0% 47.37%
% of Gross Profit 818.18% 509.09%
Operating Expenses $2.544M $3.017M $2.020M
YoY Change 21.78% 49.36%
Operating Profit -$2.533M -$3.006M -$2.020M
YoY Change 21.25% 48.81% 60.96%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change
Pretax Income -$2.533M -$3.006M -$2.020M
YoY Change 21.25% 48.81%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.533M -$3.006M -$2.020M
YoY Change 21.25% 48.81% 60.96%
Net Earnings / Revenue -11013.04% -13069.57%
Basic Earnings Per Share
Diluted Earnings Per Share -$6.487M -$7.718M -$5.179M
COMMON SHARES
Basic Shares Outstanding 7.812M shares 7.803M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.07M $12.61M
YoY Change
Cash & Equivalents $10.07M $12.61M $0.00
Short-Term Investments
Other Short-Term Assets $360.0K $350.0K
YoY Change
Inventory $150.0K $129.0K
Prepaid Expenses $349.0K
Receivables
Other Receivables
Total Short-Term Assets $10.65M $13.10M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $1.038M $760.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.038M $760.0K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $10.65M $13.10M
Total Long-Term Assets $1.038M $760.0K
Total Assets $11.69M $13.86M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $434.0K $410.0K
YoY Change
Accrued Expenses $350.0K $300.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $825.0K $870.0K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $825.0K $870.0K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $825.0K $870.0K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$7.513M -$4.980M
YoY Change
Common Stock $78.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.86M $12.99M
YoY Change
Total Liabilities & Shareholders Equity $11.69M $13.86M
YoY Change

Cashflow Statement

Concept 2014 Q2 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income -$2.533M -$3.006M -$2.020M
YoY Change 21.25% 48.81% 60.96%
Depreciation, Depletion And Amortization $90.00K $56.00K $38.00K
YoY Change 125.0% 47.37%
Cash From Operating Activities -$2.400M -$1.410M -$1.930M
YoY Change 26.32% -26.94%
INVESTING ACTIVITIES
Capital Expenditures -$260.0K $242.0K $18.00K
YoY Change 766.67% 1244.44%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$260.0K -$240.0K -$20.00K
YoY Change 766.67% 1100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $247.0K $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 110.0K 250.0K 1.950M
YoY Change -94.3% -87.18%
NET CHANGE
Cash From Operating Activities -2.400M -1.410M -1.930M
Cash From Investing Activities -260.0K -240.0K -20.00K
Cash From Financing Activities 110.0K 250.0K 1.950M
Net Change In Cash -2.550M -1.400M 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$2.400M -$1.410M -$1.930M
Capital Expenditures -$260.0K $242.0K $18.00K
Free Cash Flow -$2.140M -$1.652M -$1.948M
YoY Change 14.44% -15.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Assets Current
AssetsCurrent
13100000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
14489000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1974000 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13860000 USD
us-gaap Gross Profit
GrossProfit
22000 USD
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
76000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
719000 USD
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
840000 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1724000 USD
CY2014Q1 us-gaap Cash
Cash
12607000 USD
CY2013Q4 us-gaap Cash
Cash
14008000 USD
CY2014Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
15000 USD
CY2013Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
22000 USD
CY2014Q1 us-gaap Inventory Net
InventoryNet
129000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
38000 USD
CY2014Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
349000 USD
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
421000 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
760000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
575000 USD
CY2014Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
760000 USD
CY2013Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
575000 USD
CY2014Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
162000 USD
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
90000 USD
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17893000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16466000 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4980000 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
12988000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
14569000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15064000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10312000 USD
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7804803 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7742080 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7804803 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7742080 shares
CY2013Q4 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
15000000 USD
CY2014Q1 hart Percentage Of Revenue And Receivables From Related Parties
PercentageOfRevenueAndReceivablesFromRelatedParties
1 pure
CY2014Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
26000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7000 USD
CY2014Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
103000 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
31000 USD
CY2013Q1 us-gaap Revenues
Revenues
0 USD
CY2014Q1 us-gaap Revenues
Revenues
23000 USD
us-gaap Revenues
Revenues
45000 USD
CY2013Q1 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
12000 USD
us-gaap Cost Of Revenue
CostOfRevenue
23000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
0 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
11000 USD
CY2013Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1217000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13212000 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
2020000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
3017000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2020000 USD
us-gaap Net Income Loss
NetIncomeLoss
-24221000 USD
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7740000 shares
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7760000 shares
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
136000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1176000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3454000 USD
CY2013Q1 us-gaap Depreciation
Depreciation
38000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12607000 USD
CY2014Q1 us-gaap Depreciation
Depreciation
56000 USD
us-gaap Depreciation
Depreciation
294000 USD
CY2013Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
0 USD
CY2014Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-7000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
15000 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
91000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
129000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
5000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-72000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
349000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
13000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
162000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
406000 USD
CY2013Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
0 USD
CY2014Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
72000 USD
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
162000 USD
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-94000 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
143000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
304000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1932000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1409000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-20094000 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
242000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1055000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-18000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-242000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1055000 USD
CY2013Q1 hart Proceeds From Investment Made By Parent Company
ProceedsFromInvestmentMadeByParentCompany
1950000 USD
CY2014Q1 hart Proceeds From Investment Made By Parent Company
ProceedsFromInvestmentMadeByParentCompany
0 USD
hart Proceeds From Investment Made By Parent Company
ProceedsFromInvestmentMadeByParentCompany
33503000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
247000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
250000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1950000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
247000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
33753000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1401000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12607000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14008000 USD
CY2009Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Trading Symbol
TradingSymbol
HART
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7812136 shares
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
Harvard Apparatus Regenerative Technology, Inc.
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001563665
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2020000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3006000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24221000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2020000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3009000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24224000 USD
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
0 USD
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
3000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
3000 USD
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
250000 USD
CY2014Q1 hart Product Distribution Agreement Term
ProductDistributionAgreementTerm
P10Y
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
306000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
248000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD

Files In Submission

Name View Source Status
0001144204-14-031376-index-headers.html Edgar Link pending
0001144204-14-031376-index.html Edgar Link pending
0001144204-14-031376.txt Edgar Link pending
0001144204-14-031376-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hart-20140331.xml Edgar Link completed
hart-20140331.xsd Edgar Link pending
hart-20140331_cal.xml Edgar Link unprocessable
hart-20140331_def.xml Edgar Link unprocessable
hart-20140331_lab.xml Edgar Link unprocessable
hart-20140331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v378175_10q.htm Edgar Link pending
v378175_ex31-1.htm Edgar Link pending
v378175_ex31-2.htm Edgar Link pending
v378175_ex32-1.htm Edgar Link pending
v378175_ex32-2.htm Edgar Link pending